Barclays’s Avalon GloboCare ALBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-18
Closed -$2K 4103
2021
Q3
$2K Sell
18
-16
-47% -$2.32K ﹤0.01% 4660
2021
Q2
$5K Sell
34
-78
-70% -$12.4K ﹤0.01% 4741
2021
Q1
$18K Buy
112
+69
+160% +$13K ﹤0.01% 4385
2020
Q4
$8K Sell
43
-18
-30% -$3.21K ﹤0.01% 4763
2020
Q3
$11K Sell
61
-14
-19% -$3.19K ﹤0.01% 4982
2020
Q2
$21K Buy
75
+27
+56% +$6.6K ﹤0.01% 5191
2020
Q1
$12K Sell
48
-97
-67% -$22.1K ﹤0.01% 5772
2019
Q4
$42K Buy
145
+73
+101% +$18.3K ﹤0.01% 5779
2019
Q3
$20K Sell
72
-22
-23% -$6.93K ﹤0.01% 6207
2019
Q2
$36K Sell
94
-20
-18% -$9.04K ﹤0.01% 6227
2019
Q1
$92K Buy
+114
New +$76.2K ﹤0.01% 5420

Other funds holding ALBT

Barclays's ALBT Position: Q4 2021 in Review

Barclays sold out of Avalon GloboCare (ALBT) in Q4 2021, closing a stake of 18 shares — an estimated $2K sold.

Barclays first reported a position in ALBT in Q1 2019 and held it in 11 quarters. The position peaked at $92K in Q1 2019. 16 funds tracked by Wall St. Rank hold ALBT as of Q4 2021.

  • Barclays reported no remaining Avalon GloboCare position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 18 Avalon GloboCare shares in Q4 2021, an estimated $2K.
  • Barclays first reported a position in Avalon GloboCare in Q1 2019 and held it in 11 quarters.
  • Barclays's Avalon GloboCare position peaked at $92K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Avalon GloboCare as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.